Laurion Capital Management LP Autolus Therapeutics PLC Transaction History

Laurion Capital Management LP

$3.86 Billion
Q1 2025

A detailed history of Laurion Capital Management LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Laurion Capital Management LP holds 3,369,248 shares of AUTL stock, worth $8.46 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

3,369,248

Previous 3,189,547 5.63%

Holding current value

$8.46 Million

Previous $7.5 Million 30.33%

% of portfolio

0.14%

Previous 0.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.55 - $2.68 $278,536 - $481,598	179,701 Added 5.63%	3,369,248 $5.22 Million
Q3 2024 Nov 14, 2024	SELL	$3.38 - $4.69 $1.54 Million - $2.14 Million	-456,683 Reduced 12.52%	3,189,547 $11.6 Million
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $5.18 Million - $8.84 Million	1,555,759 Added 74.42%	3,646,230 $12.7 Million
Q1 2024 May 15, 2024	BUY	$5.39 - $7.29 $6.49 Million - $8.78 Million	1,205,000 Added 136.09%	2,090,471 $13.3 Million
Q4 2023 Feb 14, 2024	SELL	$2.13 - $6.63 $1.31 Million - $4.07 Million	-614,529 Reduced 40.97%	885,471 $5.7 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $2.61 Million - $4.91 Million	1,500,000 New	1,500,000 $2.85 Million
Q2 2021 Aug 13, 2021	SELL	$4.78 - $7.96 $730,608 - $1.22 Million	-152,847 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.49 - $9.36 $839,130 - $1.43 Million	152,847 New	152,847 $876,000
Q3 2020 Nov 13, 2020	SELL	$11.64 - $16.3 $785,921 - $1.1 Million	-67,519 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.38 - $16.14 $275,536 - $826,610	-51,215 Reduced 43.13%	67,519 $1.08 Million
Q1 2020 May 14, 2020	BUY	$4.2 - $13.0 $498,682 - $1.54 Million	118,734 New	118,734 $711,000
Q3 2019 Nov 13, 2019	SELL	$9.79 - $16.72 $443,624 - $757,650	-45,314 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.1 - $31.25 $684,241 - $1.42 Million	45,314 New	45,314 $730,000
Q4 2018 Feb 14, 2019	SELL	$24.21 - $48.01 $585,639 - $1.16 Million	-24,190 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$20.86 - $33.33 $1.06 Million - $1.69 Million	-50,810 Reduced 67.75%	24,190 $730,000
Q2 2018 Aug 13, 2018	BUY	$25.0 - $27.75 $1.88 Million - $2.08 Million	75,000 New	75,000 $2.01 Million

Others Institutions Holding AUTL

# of Institutions

Shares Held

163M

Call Options Held

Put Options Held

88.3K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $228M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account

Laurion Capital Management LP Autolus Therapeutics PLC Transaction History